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Influence of Friedreich Ataxia GAA
Noncoding Repeat Expansions on Pre-mRNA Processing
Marco Baralle,1,2 Tibor Pastor,1,2 Erica Bussani,1 and Franco Pagani1,*
The intronic GAA repeat expansion in the frataxin (FXN) gene causes the hereditary neurodegenerative disorder Friedreich ataxia.
Although it is generally believed that GAA repeats block transcription elongation, direct proof in eukaryotic systems is lacking.We tested
in hybrid minigenes the effect of GAA and TTC repeats on nascent transcription and pre-mRNA processing. Unexpectedly, disease-caus-
ing GAA100 repeats did not affect transcriptional elongation in a nuclear HeLa Run On assay, nor did they affect pre-mRNA transcript
abundance. However, they did result in a complex defect in pre-mRNA processing. The insertion of GAA but not TTC repeats down-
stream of reporter exons resulted in their partial or complete exclusion from the mature mRNAs and in the generation of a variety of
aberrant splicing products. This effect of GAA repeats was observed to be position and context dependent; their insertion at different
distances from the reporter exons had a variable effect on splice-site selection. In addition, GAA repeats bind to a multitude of different
splicing factors and induced the accumulation of an upstream pre-mRNA splicing intermediate, which is not turned over into mature
mRNA. When embedded in the homologous frataxin minigene system, the GAA repeats did not affect the pre-mRNA transcript abun-
dance but did signiﬁcantly reduce the splicing efﬁciency of the ﬁrst intron. These data indicate an association between GAA noncoding
repeats and aberrant pre-mRNA processing because binding of transcribed GAA repeats to a multitude of trans-acting splicing factors can
interfere with normal turnover of intronic RNA and thus lead to its degradation and a lower abundance of mature mRNA.Introduction
Friedreich ataxia (FRDA [MIM 229300]) is the most preva-
lent inherited ataxia1, with an estimated prevalence of
2–4/100,000. The neurodegenerative phenotype, associated
with primary degeneration of dorsal root ganglia, is charac-
terized by progressive sensory ataxia with onset before
25 years of age, areﬂexia, dysarthria, lower-limb areﬂexia,
decreased vibration sense, muscle weakness in the legs, and
extensor plantar response.2,3 Diabetes, skeletal abnormali-
ties, and hyperthrophic cardiomyopathy are nonneurolog-
ical symptoms, and heart failure is a frequent cause of
death. FRDA is an autosomal-recessive disorder, and most
patients are homozygous for a noncoding expanded GAA
triplet repeat sequence in the frataxin (FXN [MIM
606829] gene.4 This gene is composed of seven exons
spanning about 80 kb of genomic DNA, and the GAA re-
peats are located in the middle of an Alu sequence in the
~11-kb-long ﬁrst intron. Normal alleles have only a small
number of GAA trinucleotide repeats (usually 8–33),
whereas expanded alleles contain more than 90 repeats.1,5
An inverse correlation between the length of the GAA
expansion and the age of onset and severity of the disease
has been observed.6,7 Interestingly, large expansions of
GAA repeats are speciﬁc to mammals, and the human ge-
nome contains other genes with intronic expandable and
potential pathogenic GAA triplets.5,8 FRDA patients have
a marked deﬁciency of frataxin mRNA9 that eventually
causes a signiﬁcant reduction in the amount of frataxin
protein, which is a highly conserved protein associated
with the inner mitochondrial membrane and is involved
in mitochondrial iron metabolism.91International Centre for Genetic Engineering and Biotechnology, Padriciano
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can adopt in vitro non-B-DNA structure or sticky DNA10–15,
which can interfere with gene transcription.11,12,14,16,17
However, the majority of studies have evaluated transcrip-
tion by using phage or bacterial polymerases.14,16,17 These
prokaryotic systems cannot efﬁciently process the major-
ity of eukaryotic pre-mRNAs; for example, transcripts
derived from T7 (and also polIII) are not efﬁciently cap-
ped, spliced, and polyadenylated18,19 because these poly-
merases lack the polII-speciﬁc carboxy-terminal domain,
which provides a unique platform that connects pre-
mRNA processing with transcription.20–22 Indeed, indirect
measurement of transcription efﬁciency in eukaryotic sys-
tems showed contradicting results with reduced transcrip-
tion11,12,14 or no effect.14,23 GAA triplets have also been
found to interfere with DNA replication10,12,24 and to
mediate position-effect variegation.25 Recently, they
have been also associated with a transcriptionally silent
chromatin.26,27
Accurate mRNA biosynthesis requires both the classical
splicing signals (the 50 and 30 splice sites, the branch-point
and polypyrimidine sequences31) and a large number of
highly degenerate intronic and exonic cis-acting regula-
tory elements.28–30 The latter have been found to be a
frequent target of mutations that cause aberrant splic-
ing.28,30,32 For example, through the speciﬁc binding of
intronic repetitions to splicing factors, changes in the
number of these repetitions are known to cause different
human pathologies affecting pre-mRNA splicing. Tran-
scribed GU, CA, and expanded CUG repeats are involved
in cystic ﬁbrosis (CF [MIM 219700]),33 in the regulation
of the endothelial nitric oxide synthase gene (eNOS99, Trieste 34012, Italy
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[MIM 163729])34, and in myotonic dystrophy (DM [MIM
160900]),32 respectively. Interestingly, some intronic splic-
ing regulatory sequences have been recently shown to
facilitate the formation of pre-mRNA splicing intermedi-
ates acting selectively on the splicing efﬁciency of up-
stream or downstream introns.35
In this study, we have explored the effect of the GAA
repeats on polII transcription and pre-mRNA processing
by using hybrid minigenes as a model system. Our results
indicate that GAA repeats can be efﬁciently transcribed
and inserted in nascent pre-mRNAs, where they can bind
to multiple splicing factors and affect the pre-mRNA pro-
cessing in a position- and context-dependent manner. To
explain the composite effect of the repeats, transcribed
GAA triplets could form a ‘‘sticky RNA,’’ which interferes
with normal intronic pre-mRNA processing.
Material and Methods
Plasmid Construction
The pEDA minigene was previously described36 and contains the
genomic ﬁbronectin EDA exon, its ﬂanking introns, and part of
the 1 and þ1 exons embedded in the human a-globin gene un-
der the control of the SV40 enhancer. To generate the pEDA Nco,
pEDA Nde, and pEDA BclI, we individually modiﬁed the corre-
sponding unique restriction sites in the downstream EDA intron
to the KpnI site by inserting speciﬁc oligonucleotides. We inserted
a 40 bp spacer derived from pBS in the HindIII site of the second
a-globin exon to obtain pEDA BglII. For generating the pBRCA1
ex18 minigene, a BRCA1 exon 17, exon 18, and exon 19 cassette
was ampliﬁed by PCR and cloned in the BstEII site in the third
exon of the a-globin minigene.37 A frataxin cassette, which in-
cluded 180 nucleotides of the ﬁrst exon, 1170 bases of the ﬂanking
intron, the last 786 bases of the intron, and 78 bases of the frataxin
exon 2, was ampliﬁed in two fragments with Fra395Dir and
Fra1750RevKpn, Fra10314Dir, and Fra11100RevXba, respectively
(oligonucleotide sequences are provided in the Supplemental
Data), and cloned in pCDNA3 to obtain the pFrx minigene. One
hundred GAA or TTC repeats were obtained by PCR ampliﬁcation
with primers C27 dir and C27Rev on genomic DNA and inserted
in the unique KpnI site sites of pEDA and pFrx constructs. The
same number of repeats were ampliﬁed with speciﬁc primers and
cloned in the unique BamHI and EcoRI sites of pCF ex938 and
pBRA,37 respectively. The human genomic frataxin sequence
containing 217 GAA repeats was ampliﬁed from human FRDA
transgenic YG22 mouse DNA39 with primers GAA1724Dir and
GAA2192Rev, digested with KpnI, and cloned in sense and
antisense orientation in the pEDANco minigene to generate
pEDANcoGAA217 and pEDANcoTTC217. Oligonucleotides with
ﬁfteen GAA or TTC repeats were inserted in pEDA Nde to gener-
ate pEDANde15TTC and pEDANde15GAA. All minigenes were
veriﬁed by sequencing, and the correct size of repeat insertions
was checked for every plasmid preparation.
Transfection, RT-PCR Analysis, Northern Blotting,
and Nuclear Run On Assay
COS7 cells (2.5 3 105) or HeLa cells p100 (5 3 106) were grown in
standard conditions and transfected with Effectene reagent with
1.5 mg or 3 mg of plasmid DNA, respectively.40 RNA extraction,78 The American Journal of Human Genetics 83, 77–88, July 2008RT-PCR, and quantitation of the ampliﬁed products were done
as previously described.40 For the analysis of spliced forms,
pEDA minigenes were ampliﬁed with primers a2-3 and EDA5,
pBRCA1 exon 18 was ampliﬁed with BRC90 and glo800, pCF
exon 9 was ampliﬁed with a2-3 and BRA238, and pFrx was ampli-
ﬁed with Fra395Dir and Sp6. For nascent transcript analysis, total
RNA was digested with DNase RNase free (Roche), puriﬁed with
the RNeasy kit (QIAGEN), and subsequently ampliﬁed with
speciﬁc primers. For the EDA minigene, we used the following:
for u1, EDA1207D and EDA1251Rev; for d1, EDAþ1F and
EDA1940Rev; and for d2, EDA2764Dir and glo800. For the
pFrx minigene, we used the following oligonucleotides: for U,
Fra395Dir and Fra606Rev; for D, Fra10902Dir and Sp6; and for
D1, Fra10754Dir and Fra11037Rev. For turnover of splicing inter-
mediates, we ampliﬁed the transfected minigenes with a936 and
EDA1251R to detect the upstream intermediates and with
EDA1207D and glo395 to detect the downstream intermediates.
The relative abundance of spliced and unspliced forms in the Frx
minigene was analyzed by RT-PCR with primers speciﬁc for the
ﬂanking exons (Fra395Dir and Sp6) and/or for the intronic
sequences (Fra606Rev and Fra10902Dir). To detect the spliced
and U unspliced forms, we ampliﬁed the transfected pFrx mini-
genes with Fra395Dir, Fra606Rev, and Sp6 primers. Ampliﬁcation
with Fra395Dir, Fra10902Dir, and Sp6 primers allowed detection
of the spliced and D unspliced forms. The ampliﬁed products
were resolved on 2% agarose gels, and the relative efﬁciency of
splicing was measured as the ratio between the intensity of the
band originating from the mature spliced transcript and that orig-
inating from the unspliced pre-mRNAs.
For Northern analysis, total RNA (2 mg) was resolved on 1.2%
agarose-formaldehyde gel, and blotted membranes were hybrid-
ized with a32PdCTP-labeled a-globin cDNA or with the 270 bp
EDA ﬁbronectin alternative spliced exon.
For NRO analysis, nuclei from HeLa-transfected cells were
isolated in hypertonic lysis buffer (10 mM Tris HCl [pH 7.5],
10 mM NaCl, 2.5 mM MgCl2, 0.5% NP40, and 10% sucrose) and
resuspended in transcription buffer (40 mM Tris HCl [pH 7.9],
500 mM KCl, 10 mM MgCl2, 40% glycerol, and 2 mM DTT) in
the presence of 32P pUTP and 32P pGTP for 15 min at 30C. After
RNA extraction, the labeled nascent RNAs were isolated and
hybridized to antisense single-strand M13 probes slot blotted
on nylon membrane. Radioactive signals were quantitated on a
Cyclon Imager. We obtained the A-to-F M13 probes spanning the
pEDAminigene by cloning the different PCR-ampliﬁed sequences
in M13 plasmid. The VA M13 probe for normalization of transfec-
tion efﬁciencies was a generous gift fromN. Proudfoot. Each trans-
fectionwas VA normalized, and data were expressed for each probe
as a percentage relative to the values obtained with the pEDA
construct.
Afﬁnity Puriﬁcation of RNA-Binding Proteins:
Pull-Down Assay
Two synthetic (GAA)10 and (UUC)10 RNA oligonucleotides (Inte-
grated DNA Technologies) were used as targets for pull-down
assays. An amount of 10 mg of either target RNA oligo was placed
in 400 ml of reaction mixture (100 mM NaAcetate [pH 5.0] and
Sigma 5 mM sodium m-periodate), incubated for 1 hr in the
dark at room temperature, precipitated with ethanol, and resus-
pended in 100 ml of 100 mM sodium acetate (pH 5.0). Approxi-
mately 400 ml of adipic acid dehydrazide agarose beads 50% slurry
(Sigma) previously equilibrated with 100 mM sodium acetate
Figure 1. Expanded GAA- and TTC-
Triplet Repeats Did Not Affect the Levels
of Nascent Transcription
(A) Schematic representation of pEDA mini-
genes. Gray and white boxes correspond to
a-globin and fibronectin exonic sequences,
respectively; lines indicate intronic
sequences. The position of the GAA and
TTC repeats is indicated. The position of
the u1, d1, and d2 nascent-transcript
amplification products is indicated. The
length and position of the M13 antisense
Nuclear Run On probes relative to the mini-
genes are shown.
(B) Typical NRO analysis of HeLa cells. Cells
were transfected with one of the indicated
minigenes together with the cotransfec-
tion control VA construct. M13 corresponds
to the empty M13 vector. Antisense single-
strand M13 probes (A to F and VA) are indi-
cated at the top.
(C) The graph shows the VA-normalized
quantitation of three independent transfections relative to the values obtained with the pEDA (black columns) constructs over the
corresponding probes. Data are expressed as means þ SD. Light-gray and white columns show transcription levels obtained with pEDA
NcoGAA and pEDA NcoTTC minigenes. All signals are corrected for the background hybridization shown in the M13-negative control.
(D) Analysis of pre-mRNA transcript abundance. The indicated minigenes were transfected in COS cells, and the resulting RNAs were coam-
plified with the u1-d1 (top) or u1-d2 (bottom) primer set and resolved on agarose gels. The pEDA without repeats is indicated with Ø.
Controls without reverse transcriptase (RT) and untransfected cells (C) are indicated. M is the molecular 1 Kb marker.(pH 5.0) was added to each periodate-treated RNA, and the mix
was incubated for 12 hr at 4C on a rotator.
The beads with the bound RNA were then washed three times
with 1 ml of 2 M NaCl, equilibrated in 13 solution D (20 mM
HEPES [pH 7.5], 100 mM KCl, 0.2 mM EDTA, 0.5 mM DTT, and
6% glycerol) and incubated, in a ﬁnal volume of 500 ml, with
0.5 mg of HeLa cell nuclear extract (C4, Biotech), 103 solution D
(200 mM HEPES [pH 7.5], 2 mM EDTA, 5 mM DTT, and 60% glyc-
erol), 160mMKCl, andHeparin (ﬁnal concentration 2.5 mg/ml), for
30 min on a rotator at room temperature. The beads were then
washed six times with 1 ml of 13 solution D before the addition
of SDS sample buffer and loading on SDS-12% polyacrylamide
gels. Proteins were visualized by Coomassie brilliant blue staining.
Protein sequence analysis of the bands excised from the gel was
performed with an electrospray ionization mass spectrometer
(LCQ DECA XP-ThermoFinnigam). Protein bands were digested
with trypsin, and the resulting peptides were extracted with water
and 60% acetonitrile/1% triﬂuoroacetic acid. Fragments were then
analyzed by mass spectrometry, and proteins were identiﬁed by
analysis of the peptideMS/MS data with Turbo SEQUEST (Thermo-
Finnigam) and MASCOT (Matrix Science).
Immunoblots were performed onto PVDF membrane (Amer-
sham Bioscience), which was blocked by incubation in 5% dried
milk in 0.1 M PBS, 0.1% Tween-20, or for Mab 1H4, in 13Western
Blocking Reagent (Roche). Membranes were probed with primary
antibodies raised against hnRNPA1 and hnRNPA2 (kindly pro-
vided by R. Klima, ICGEB, Italy; 1:1000), PTB (a kind gift from
E. Buratti, ICGEB, Italy; 1:1000), ZNF 9 (kindly provided by B. Cardi-
nali; 1:1000), PABPN1 (a kind gift from E. Wahle, Halle, Germany;
1:1000), ASF/SF2 (Zymed Laboratories; 1:1000), SR proteins (Map
1H4, Zymed Laboratories; 1:1000) and Tra2b (Abcam; 1:1000). Im-
munoreactive bands were detected with enhanced chemiluminis-
cence reagent (ECL; Amersham Biosciences).Results
GAA Repeats Did Not Affect Transcription Elongation
or Pre-mRNA Transcript Abundance in Transfected
Cells
To test the effect of GAA repeats on PolII elongation and
pre-mRNA transcript abundance, we used the alternatively
spliced ﬁbronectin pEDA minigene. This minigene has
been extensively studied36,41 and provides a good model
for studying the process of cotranscriptional splicing and
splicing regulatory sequences.42–44 One hundred GAA or
TTC repeats were introduced in the NcoI site of the pEDA
construct (Figure 1A). This size expansion, found in affected
individuals, has been shown to form abnormal DNA struc-
tures in vitro13,14,45 and to inhibit prokaryotic polymerase
transcription.16Weperformedanuclear runon (NRO) assay
to determine whether some differences in the transcription
level could be observed between minigenes carrying the
GAA or TCC expansion and the empty minigene. Analysis
was performed with single-strand, antisense DNA probes
that cover the minigene sequences upstream and down-
stream of the triplet repeats (Figure 1A). Cotransfection
with the VAI-expressing plasmid was used as a control for
transfection efﬁciency. NRO signals obtained for the GAA,
TTC, or empty pEDA minigenes were comparable relative
to theVAI control signal, resulting in no changes innascent
transcription (Figure 1B). Quantitation of three indepen-
dentVAInormalized transfections conﬁrmed that the inser-
tion of either the GAA or TTC repeat did not affect pre-
mRNA transcription levels (Figure 1C), as shown by theThe American Journal of Human Genetics 83, 77–88, July 2008 79
Figure 2. Effect of GAA and TTC Repeats
on Pre-mRNA Splicing in pEDA Hybrid
Minigenes
(A) Schematic representation of pEDA min-
igenes. Gray and white boxes correspond to
a-globin and fibronectin exonic sequences,
respectively, and lines indicate intronic se-
quences. The position and cloning sites of
the GAA and TTC repeats (n ¼ 100) are in-
dicated. Arrows represent the primers used
in amplification experiments.
(B) Schematic representation of the aber-
rant splicing product in pEDA NcoGAA and
pEDA NdeGAA minigenes as derived from
PCR and Northern analysis. Dotted lines
indicate the aberrant splicing choices,
and gray lines indicate the intron (IVS)
retentions.
(C) RT-PCR analysis. Minigenes were trans-
fected in COS cells, and the splicing pat-
tern was evaluated with a2-3 and EDA5
primers. Aberrant splicing forms in pEDA
NcoGAA and pEDA NdeGAA are numbered.
(D) Northern analysis. Minigenes were
transfected in COS cells, and the resulting RNA was analyzed by Northern blotting with an a-globin (upper) or fibronectin EDA (lower)
probes. Control D2e and D4 are EDA minigene mutants that showed complete exon skipping and inclusion, respectively.36 Ribosomal
RNAs and the two alternative spliced forms with and without the EDA exon are indicated. Aberrant splicing forms in pEDA NcoI GAA
and pEDA NdeI GAA are numbered.presence of similar amounts of transcribed RNA along the
two minigenes and the empty pEDA. We also evaluated
the relative abundance of nascent transcript before and af-
ter the triplet insertion in each of pEDA minigenes by RT-
PCR. Pre-mRNA sequences, upstream (u1) and downstream
(d1 or d2) of the GAA/TTC insertion, were coampliﬁed (u1
plus d1 and u1 plus d2) from pEDA Nco, pEDA NcoGAA,
and pEDANcoTTC transfections. The ratio of two bands re-
sulting from of u1-d1 and u1-d2 coampliﬁcations showed
similar patterns in the pEDA Nco, pEDA NcoGAA, and
pEDA NcoTTC, indicating that the type of insertion has
no effect on the relative amount of nascent transcripts
before and after the insertions (Figure 1D). Similarly, an in-
creased number of triplets (n ¼ 217) inserted in the pEDA
minigene did not affect the relative abundance of the na-
scent transcripts before and after the insertion (Figure S1).
In summary, these results clearly demonstrate that the
insertion of a disease-causing GAA repeat expansion in a
mammalian reporter gene did not affect the polII transcrip-
tion elongation or pre-mRNA transcript abundance.
GAA Repeats Affect Pre-mRNA Splicing
in a Position-Dependent Manner in a Heterologous
Hybrid Minigene System
The lack of any effect on transcription in the pEDA
NcoGAA minigene was unexpected, and we decided to ex-
plore in more detail the effect of the repeats on the mRNA
biosynthesis. TheGAAor TTC repeats (n¼ 100)were cloned
in different intronic positions along the entire pEDA con-
struct, and the resulting minigenes were transfected in80 The American Journal of Human Genetics 83, 77–88, July 2008COS cells. The quality of the resulting RNAs was evaluated
in parallel by two complementary approaches: by RT-PCR
analysis with speciﬁc primers (Figure 2C) and by Northern
analysis (Figure 2D). RT-PCR analysis can provide an easy
way to analyze aberrant splicing, but as a result of the in-
trinsic characteristics of PCR, large-intron retention or pe-
culiar aberrant splicing products can be missed by this
technique. Interestingly, the insertion of the GAA repeats
in the NcoI position (pEDA NcoGAA) induced two major
events in comparison with the corresponding TTC mini-
gene: complete exclusion of the EDA exon, as can be
seen by RT-PCR and Northern analysis (Figures 2C and
2D), and retention of upstream and downstream introns.
This latter event can be well appreciated only by Northern
blot (aberrant band number 1, Figure 2D). To rule out po-
tential interference with splicing regulatory elements at
the cloning Nco site, which is in close proximity of the
EDA exon, we inserted the repeats 400 bp downstream at
the NdeI site. pEDA Nde GAA again showed an aberrant
splicing product. In RT-PCR the normal EDA inclusion
product disappeared and was replaced by a higher MW
band (band 4 in Figure 2C). Sequencing of band 4 showed
that it contained the EDA exon and a cryptic exon, which
surprisingly included the entire GAA sequence (Figure 2B).
In addition, Northern analysis showed two more bands
(numbers 3 and 3b in Figure 2D). Their size and hybridiza-
tion pattern indicates that band 3 corresponds to complete
retention of the downstream intron (Figure 2B), whereas
the faint 3b band probably corresponds to intron retention
of the segment upstream or downstream of the GAA
insertion. Lastly, insertion of the repeats farther down-
stream had no effect on pre-mRNA processing (pEDA BclI
constructs, Figure 2) suggesting that the number of GAA re-
peats affects splicing in a position-dependent manner.
The Number of Repeats Affects Abnormalities
in Pre-mRNA Splicing
Because the number of GAA repeats is associated with
disease severity in FRDA patients, we tested the effect of
different repeat lengths on pre-mRNA splicing in hybrid
minigenes. We created two additional pEDA minigenes
by embedding 15 GAA or 15 TTC repeats within the
NdeI restriction site and evaluated their splicing patterns.
Compared to the construct with 100 TTC repeats, pEDA
Nde(TTC)15 had no effect on the normal splicing pattern
(Figure 3A). On the contrary, pEDA Nde(GAA)15 shifted
the pre-mRNA processing toward normal splicing in com-
parison with pEDA Nde(GAA)100, although this low num-
ber of repeats still has a pathological effect in the minigene
in that it induces an aberrant splicing form with retention
of the downstream intron (Figure 3, band 3).
GAA Repeats Affect Pre-mRNA Processing in Two
Additional Heterologous Minigenes
To test whether the effect of the repeats on pre-mRNA
processing was a peculiarity of the alternatively spliced
ﬁbronectin EDA minigene, we extended the study to two
additional minigenes (Figure 4A). The GAA or TTC repeats
were inserted downstream of the constitutively included
Figure 3. The Number of GAA Repeats Affects the Severity of
the Aberrant Splicing Pattern
(A) Northern analysis of pEDA Nde minigenes with 100 or 15 GAA or
TTC repeats. Minigenes were transfected in COS cells, and the re-
sulting RNA was analyzed by Northern blotting with an a-globin
probe. Ribosomal RNAs and the two alternative spliced forms
with and without the EDA exon are indicated. Aberrant splicing
forms in pEDA Nde GAA100 and pEDA NdeI GAA15 are numbered.
(B) Schematic representation of the splicing products observed in
in pEDA Nde GAA100 and pEDA NdeI GAA15 as deduced from North-
ern analysis and the sequencing of aberrant products in RT-PCR
analysis. Dotted lines indicate the aberrant splicing choices, and
gray lines indicate the intron (IVS) retentions.BRCA1 exon 18 and downstream of the aberrant alterna-
tively spliced CFTR exon 9 (Figure 4A). mRNAs were then
evaluated by RT-PCR and Northern analysis. In the pres-
ence of the GAA repeats but not TTC, both BRCA1 exon
18 and CFTR exon 9 showed aberrant splicing products
similar to those found in the EDA minigene. In particular,
the pBRCA1 ex18GAA produces an aberrant band (num-
ber 1) that contains the GAA repeats followed by the
downstream intronic sequences (Figure 4B). The pCF ex
9 GAA revealed a complex aberrant splicing pattern in
which exon 9 was skipped, GAA was used as a cryptic
exon, and downstream introns were retained (Figure 4).
These different aberrant splicing products were also ob-
served in Northern blots (Figure 4D) and are represented
schematically in Figure 4E.
Figure 4. Effect of GAA-TTC Repeats in BRCA1 Exon 18 and
CFTR Exon 9
(A) Schematic representation of minigenes containing the GAA or
TTC (n ¼ 100) repeats. Gray boxes correspond to a-globin se-
quence, and white boxes correspond to BRCA1 and CFTR exons.
Lines indicate intronic sequences. Arrows represent the primers
used in amplification experiments.
(B) RT-PCR analysis. Minigenes were transfected in COS cells, and
the splicing pattern was evaluated with specific primers. Exon in-
clusion (þ) and exclusion (-) as well as aberrant splicing (num-
bers) are indicated.
(C) Northern analysis. Minigenes were transfected in COS cells, and
the resulting RNA was analyzed by Northern blotting with an a-glo-
bin probe. The basic pGlo minigene that contains the a-globin se-
quences with a short endogenous promoter showed a double band,
which is due to alternative transcript initiation. Ribosomal RNAs
are indicated. Aberrant splicing forms in pBRCA1ex18 GAA and
pCFex9 GAA are numbered.
(D) Schematic representation of the aberrant splicing products ob-
served in pBRCA1ex18 GAA and pCFex9 GAA. Dotted lines indicate
the aberrant splicing choices, and gray lines indicate the intron
(IVS) retentions.The American Journal of Human Genetics 83, 77–88, July 2008 81
Figure 5. Turnover of Pre-mRNA Inter-
mediates in pEDA Nco Minigenes
(A) Schematic representation of the hybrid
minigenes used for evaluation of the splic-
ing intermediates. The gray box corre-
sponds to a hybrid a-globin fibronectin
exon that is partially skipped in the up-
stream intermediates, and the black box
is the 40 bp insertion in pEDA BglII. The
indicated primer pairs a936–EDA1251R
and EDA1207D-glo395 amplify, relative to
the EDA exon, the upstream and down-
stream intermediates, respectively.
(B) Analysis of downstream intermediates.
pEDA NcoGAA and pEDA NcoTTC minigenes
were transfected in COS cells, and pre-
mRNA was amplified with EDA1207D and
glo395. The splicing product is shown,
and its identity was verified by direct
sequencing.
(C) Analysis and relative quantitation of
upstream intermediates. Cotransfection
experiments and RT-PCR amplification
with a936 and EDA1251R are shown. Equal
amounts of pEDA NcoGAA and pEDA NcoTTC (250 ng) were transfected in COS cells alone or in combination with different amounts of
pEDA BglII (250 ng in lanes 3–5; 1 mg in lane 6; and 2 mg in lane 7). The major upstream intermediates originating from pEDA NcoGAA
and pEDA NcoTTC (iUP) or from pEDA BglII (iUP Bg) are indicated.Turnover of Pre-mRNA Splicing Intermediates
in the pEDA Nco GAA Minigene
To investigate the GAA-dependent aberrant splicing mech-
anism more in detail, we evaluated the turnover of pre-
mRNA splicing intermediates in pEDA NcoGAA and
pEDA NcoTTC minigenes. Preferential activation of one
pre-mRNA splicing intermediate (i.e., of an upstream or
downstream intron) has been recently shown to regulate
splice-site selection throughdifferential binding of a neuro-
nal speciﬁc splicing factor to intronic or exonic se-
quences.35 In order to study the splicing intermediates in
the pEDA Ncominigenes carrying the TTC or GAA repeats,
we used two pairs of primers: the 1207D and glo395R pair
and the a936 and EDA1251R pair. The ﬁrst pair of primers
detects intermediates containing the intron upstream of
the EDA exon, whereas the second primer pair detects in-
termediates containing the intron downstream of the
EDA exon. Ampliﬁcation with EDA 1207D and glo395R
showed a band corresponding to the removal of the TTC-
containing intron of the downstream intermediate only
in the pEDA TTC minigene (Figure 5B). The absence of
any ampliﬁed band in pEDA NcoGAA is consistent with
mature mRNA in the Northern analysis, in which this min-
igene showed complete exon skipping and the retention of
the GAA-containing intron. On the contrary, ampliﬁcation
with a936 and EDA1251R showed two bands in both
pEDANco GAA and pEDA NcoTTC plasmids (Figure 5C,
lanes 1 and 2). The major upper band corresponds to the
splicing intermediate inwhich theGAA- or TCC-containing
intron is present and all the upstream introns are correctly
removed (iUP) (Figure 5C, lanes 1 and 2, respectively),82 The American Journal of Human Genetics 83, 77–88, July 2008whereas the faint lower band was due to partial skipping
of the 1 hybrid globin-ﬁbronectin exon. In light of the
fact that the iUP intermediate represents one of the two
alternative pathways leading to exon inclusion (i.e., the
intermediate in which the upstream intron is skipped), its
presence in the GAA minigene was unexpected because
the mature mRNA completely lacks the EDA (Figure 2).
To quantify the relative amount of the iUP pre-mRNA,
we set up a cotransfection experiment with the pEDABglII
minigene. This pEDABglII internal-control minigene with-
out repeats contains a 40-bp-long insertion in the second
a-globin exon, and RT-PCR ampliﬁcation results in
a slightly higher intermediate, iUPBg (Figure 5C, lane 3).
When equal amounts of the pEDA NcoGAA and pEDA
NcoTTC were individually cotransfected with the same
amount of pEDABglII (250 ng), the iUPBg intermediate
was only evident in the pEDA NcoTTC lane, suggesting
that the iUP produced by the pEDA NcoGAA is signiﬁ-
cantly reduced (Figure 3C, compare lanes 4 and 5). To con-
ﬁrm these data, we cotransfected pEDA NcoGAA with
increasing amounts of pEDABglII (1 mg and 2.5 mg) (Fig-
ure 5, lanes 6 and 7). In light of the iUP intermediate
band, cotransfection experiments showed that approxi-
mately ten times more pEDABglII plasmid is necessary to
compete with the the pEDA NcoGAA than with the
pEDA NcoTTC minigene (Figure 5C, lanes 5–7). Thus, the
amount of iUP is signiﬁcantly higher in the pEDA NcoGAA
than in the pEDA NcoTTC. This indicates that the GAA
repeats induce a block in the turnover of the upstream in-
termediate, which accumulates and is not processed into
mature EDAþ mRNA, as shown by Northern blot analysis
(Figure 2D). One possibility is that the preferential accu-
mulation of pre-mRNA splicing intermediates might occur
through binding of trans-acting splicing factors in the
intron.35
Binding Properties of GAA-Repeat Transcripts
In order to identify trans-acting factor(s) whose binding to
GAA repeats could give us an explanation for the observed
changes in the splicing pattern, we performed a pull-down
analysis with synthetic RNA oligonucleotides containing
either 10 GAA or 10 UUC trinucleotide repeats. We de-
tected at least four protein bands that were enriched in
the GAA-repeat fraction (data not shown). These protein
bands of approximately 50, 35, and 18 kDa were excised,
analyzed by mass spectrometry, and eventually identiﬁed
as PABPN1 (Uniprot accession number Q86U42), a protein
that is involved in nuclear polyadenylation, might contrib-
ute to mRNA export46, and has an antiapoptotic role47; as
hnRNPA1 and hnRNPA2 (Uniprot accession numbers
P09651 and P22626, respectively), a well-known factor
involved in splicing inhibition31; and as ZNF9 (Uniprot
accession number P62633), whose function is yet to be un-
derstood.48 The protein doublet associated with UUC oli-
gonucleotide corresponds to the PTB (Uniprot accession
number P26599), an important regulatory splicing pro-
tein, whose prevalent inhibitory effect on alternative splic-
ing as a result of the recognition and binding to UC-rich
sequences has already been well established.49 The differ-
ential binding properties of these proteins were further
conﬁrmed by immunoblot analysis (Figure 6). We have
Figure 6. Binding Properties of the GAA and UUC RNAs
Immunoblot after pull-down analysis of (GAA)10 and (UUC)10 ribo-
oligonucleotide sequences. Synthetic RNA oligonucleotides,
(GAA)10 and (UUC)10, were used as targets for pull-down assays.
The affinity-purified proteins pulled down by the RNAs were re-
solved on an SDS-PAGE and analyzed by immunoblotting with
anti-PTB, anti-PABPN1, anti-hnRNPA1/A2, anti-ZNF9, anti-SF2/
ASF, anti-SR proteins, and anti-Tra2b antibodies. The identity of
the splicing factors is indicated. HeLa nuclear extract (NE) was
used as a control.also included in the analysis some members of SR protein
family because these splicing factors have been previously
reported to speciﬁcally interact with GAA-rich exonic-
splicing regulatory elements.41,50,51 Our results indicate
that the GAA repeats represent the target for many differ-
ent factors involved in pre-mRNA processing. More pre-
cisely, we observed their binding capacity not only to
PABPN1, hnRNPA1, hnRNPA2, and ZNF9 proteins but
also to several SR proteins (SF2/ASF, SRp30c [Uniprot acces-
sion number Q13242], SRp40 [Uniprot accession number
Q13243], SRp55 [Uniprot accession number Q13247],
and Tra2b [Uniprot accession number P62995]), yet nota-
bly not to SRp20 (Uniprot accession number P84103),
which interactedwith theUUColigonucleotides (Figure 6).
A similar association between GAA-rich RNA molecules
and splicing factors (including several orthologous SR pro-
teins and PAPBN1) has been detected also in Xenopus
oocyte extracts.52,53
GAARepeats Inhibit Splicing in the FrataxinMinigene
We tried to assess whether the observed effect of GAA re-
peats could be reproducible when the triplets were inserted
in the frataxin minigene. The main characteristic of this
minigene is that the GAA repeats are inserted in the ﬁrst
intron, which does not allow the potential skipping of
the upstream exon. We made a frataxin minigene con-
struct that carried exon 1 with 1170 bases of downstream
intronic sequences and exon 2 with 786 bases of upstream
intronic sequences under transcriptional control of the
CMV promoter (Figure 7A). Either this empty minigene
(Ø) or the (GAA)100- and (TTC)100-containing minigenes
were transfected into COS cells. In order to evaluate the rel-
ative abundance of spliced and unspliced forms, we ana-
lyzed these constructs by RT-PCR with primers speciﬁc
for the ﬂanking exons and/or for the intronic sequences.
We conducted the analysis with coampliﬁcation experi-
ments to detect the relative efﬁciency of splicing measured
as the ratio between the mature spliced transcript and the
unspliced pre-mRNAs (see Material and Methods). Figure 7
clearly shows that the relative splicing efﬁciency of the fra-
taxin minigene was signiﬁcantly inhibited by the GAA re-
peats. In fact, the spliced-to-unspliced ratio is markedly re-
duced in the GAA minigene, and this is evident for both
the upstream (S/U) and downstream (S/D) ratio. This effect
was GAA-sequence speciﬁc given that the construct with
the TTC triplets showed a splicing efﬁciency comparable
to that of the empty one. Additional controls showed
that there was no interference from contaminating DNA
(lanes with minus RT) and that there was no background
from endogenous Frataxin mRNA (data not shown).
In parallel, we also evaluated in the frataxinminigene the
relative abundance of the nascent transcripts upstream and
downstreamof the triplet insertion (U andD1 in Figure 7A).
As found for the EDA minigene (Figure 1D), the two bands
resulting fromU and D1 coampliﬁcations showed a similar
ratio independently of the type of insertion, indicating that
the GAA repeats did not change the mRNA transcriptThe American Journal of Human Genetics 83, 77–88, July 2008 83
Figure 7. Effect of GAA-TTC Repeats on
Pre-mRNA Splicing in the Homologous
Frataxin Minigene
(A) Schematic representation of the fra-
taxin minigene containing the GAA or TTC
(n ¼ 100) repeats and showing the un-
spliced (U, D, and D1) and spliced (S) am-
plification products.
(B) Analysis of splicing efficiency. The pFrx
minigeneswere transfected in COS cells, and
RT-PCR analysis was performed so that the
S- and U-unspliced transcripts (upper gel)
or the S- and D-unspliced transcripts (lower
gel) could be detected. The identity of the
spliced and unspliced bands is indicated,
and the number below each lane is the
mean of the spliced versus unspliced ratio
from four independent experiments. Con-
trols without reverse transcriptase (RT) are
indicated. M is the molecular 1 Kb marker.
(C) The pFrx minigenes were transfected
in COS cells, and coamplification with U and D1 primer sets was performed so that pre-mRNA transcript abundance could be detected.
(D) The ratios between the various spliced (S) and unspliced (D and U) forms and between the unpliced D1 and U are expressed as meansþ
SD of four independent transfection experiments.abundance in the frataxin minigene (Figure 7C). On the
other hand, analysis by RT-PCR and Northern blot did not
reveal any signiﬁcant effect on the mature mRNA (data
not shown), indicating that the GAA repeats in their origi-
nal context do not affect the quality of the ﬁnal transcript.
Thus, we conclude that the GAA-repeat-rich region can act
as an intronic-splicing regulatory element that inhibits the
splicing efﬁciency of the ﬁrst frataxin intron.
Discussion
Despite extensive molecular investigations, the disease-
causing mechanism of the GAA repeats in FRDA is not
completely understood. GAA repeats have been associated
with the formation of peculiar non-B DNA structure or
sticky DNA, which is believed to interfere with nascent
transcription. In this study, we unexpectedly found that
the GAA-repeat expansions did not block transcription
but induced a position- and context-dependent effect on
pre-mRNA processing. Thus, inefﬁcient pre-mRNA splicing
rather than a direct transcriptional block is likely to be the
cause of lower levels of mature frataxin mRNA in FRDA.
The binding of transcribed GAA repeats to a multitude of
trans-acting splicing factors might interfere with normal
turnover of intronic RNA and thus lead to its degradation
and a lower amount of mature mRNA.
Two complementary methodologies that were used
for directly studying the transcription process, Nuclear
Run On in HeLa cells and RT-PCR analysis on nascent tran-
scripts, did not reveal any signiﬁcant change in the polII
transcript elongation and nascent transcript abundance
along the minigenes (Figure 1 and Figure S1). The number
of repeats we used has been previously reported to adopt84 The American Journal of Human Genetics 83, 77–88, July 2008a ‘‘sticky’’ DNA conformation in vitro, and this conforma-
tion is sufﬁcient to inhibit T7 or Sp6 polymerase transcrip-
tion.14,16,17 By contrast, we show here that polII elonga-
tion is not inﬂuenced by the repeat-dependent ‘‘sticky’’
DNA. In yeast, disease-causing GAA repeats (n ¼ 228) are
also efﬁciently transcribed and do not induce the accumu-
lation of truncated transcripts23, suggesting that there
are no signiﬁcant differences in the ability of the yeast
and mammalian transcription apparatuses to bypass GAA
triplets. This is probably due to the common cotranscrip-
tional pre-mRNA processing activity of the unique car-
boxy-terminal-domain structure of the large subunit of
the polymerases.20–22
To understand the role of GAA-repeat expansions in pre-
mRNA processing, we extensively evaluated the transcripts
derived from several minigenes. As a ﬁrst approach, we
tested the effect of the GAA repeat in three artiﬁcial sys-
tems in which the GAA repeats are not normally found
and subsequently analyzed the frataxin minigene that
naturally carries the repeats. GAA repeats inserted in the
three artiﬁcial splicing systems induced signiﬁcant and
complex modiﬁcations in the pre-mRNA splicing. Three
major aberrant splicing events were observed to originate
from the insertion of the GAA repeats. They consist of skip-
ping of an upstream constitutive or alternative spliced
exon, retention of intronic sequences, and usage of the
GAA repeats as a cryptic exon. The type of aberrant splicing
depends on the position used for insertion of the triplets
and on the fact that in this context the repeats are not lo-
cated in the ﬁrst intron of the gene. Interestingly, the
length of the repeat affects the severity of the splicing pat-
tern (Figure 3), consistent with the variable phenotypic
expression of the disease. On the other hand, the GAA
repeats inserted in the frataxin minigene resulted in
a signiﬁcant reduction in the splicing efﬁciency without af-
fecting the abundance of the nascent transcript. The splic-
ing inhibition was evident when both the upstream and
downstream unspliced pre-mRNA was compared to the
spliced form (Figure 6).
To clarify themechanism of GAA-induced aberrant splic-
ing, we studied the splicing intermediates generated dur-
ing processing of pre-mRNA in one minigene in more
detail. We observed that the pathological expansion in-
duces a block in the turnover of one splicing intermediate
that accumulates in the cell and is not further processed
(Figure 5). This intermediate is probably highly unstable,
not turned over into mature mRNA, and retained in the
nucleus. The accumulation of the intermediate strongly
suggests that pre-mRNA processing is blocked as a result
of interference from multiple splicing factors bound to
the nascent GAA-repeat transcript. Interestingly, the effect
of the GAA repeats on pre-mRNA splicing intermediates is
reminiscent of the recently described Nova-1 model of
action on neuronal splicing regulation. In this case, the
neuronal-speciﬁc Nova splicing factor regulates exon in-
clusion through a direct and asymmetric action on one
of the ﬂanking introns. It locally blocks or enhances the
assembly of the spliceosome and facilitates the formation
of pre-mRNA splicing intermediates.35
Our results support the notion that the expanded GAA
repeats might serve as a binding platform for many differ-
ent splicing factors, whose recruitment leads to the assem-
bly of an inhibitory splicing complex. The presence of
multiple trans-acting nuclear factors could affect the pre-
mRNA processing in a context-dependent manner and
lead to the production of aberrantly spliced forms. Thus,
GAA repeats might be considered to be large intronic
‘‘sticky RNA’’ sequences within nascent transcripts. Bioin-
formatic29 and experimental41,51 evidence has shown
that RNA sequences containing GAA are characteristic of
many exonic splicing enhancers. The majority of splicing
factors we have identiﬁed as binding to the GAA repeats
are already recognized as regulators of normal or aberrant
splicing. SR proteins are well-characterized activators of
exon recognition and can also act as molecular retention
signals of precursor mRNA.52–54 It has been recently dem-
onstrated in Xenopus oocyte extracts that GAA-rich
enhancer exonic sequences bind the same splicing factors
we report, namely the orthologous SR proteins and
PABPN1, which actually contribute to the retention of
pre-mRNA in the nucleus.52,53 Because SR proteins facili-
tate exon recognition via splicing machinery and subse-
quent nuclear export, their inappropriate intronic posi-
tioning due to the GAA expansion might cause aberrant
processing of pre-mRNA. Consequently, the turnover of
splicing intermediates will not occur, and either genera-
tion of different aberrant splicing forms deriving from
the heterologous minigenes or reduction in the splicing
efﬁciency of the ﬁrst intron in the frataxin minigene
model system will take place. Future studies will address
the mechanism by which reported GAA-binding factorscan contribute to aberrant splicing and pre-mRNA nuclear
retention.
The role of the context in determining the splicing out-
come of the GAA repeats, as previously reported for the
intronic CA dinucleotide in the eNOS gene, may explain
the different phenotypic expression previously observed
in mouse frataxin models. The nonconserved frataxin
intron 1 of themouse does not normally contain a GAA-re-
peat sequence, and in a knock-in mouse model, the inser-
tion of 230 GAA repeats in the intron was not associated
with any obvious pathological phenotype.55 By contrast,
the human genomic FRDA transgene with a similar GAA
expansion at the correct intronic position exhibits progres-
sive, although mild, FRDA-like pathology.39 It would be
interesting to compare the nascent transcripts and splicing
efﬁciency in these two different mouse models and to
characterize the contribution of the ﬂanking intronic
sequences.
Histone deacetylase (HDAC) inhibitors are under evalu-
ation as potential therapeutic compounds in FRDA for
their potential effect on frataxin transcription.26 It is im-
portant to highlight that these drugs have been shown
to be able to modify pre-mRNA splicing.56–59 For example,
in the neuromuscular disorder spinal muscular atrophy 1
(SMA1 [MIM 253300]), which results from the loss of
function of the survival of motor neuron 1 gene (SMN1
[600354]), they restore exon 7 defective splicing of the pa-
ralogue survival of motor neuron 2 gene (SMN2 [601627]),
which is not normally included in mRNA and contains
a single synonymous mutation in exon 7. This treatment
was shown to provide a sufﬁcient amount of SMN pro-
teins to compensate for the mutated SMN1 gene.56–58
The lack of a direct transcription interference of the
GAA repeats combined with the changes in pre-mRNA
turnover and splicing efﬁciency we have observed here
suggests that the effect of HDAC inhibitors on pre-
mRNA splicing rather than their effect on transcription
might be responsible for the increased mRNA abundance.
On the other hand, transfected minigenes might have
a different chromatin structure and only partially mimic
the recently described epigenetic changes observed
in vivo in patients’ cells.26,27 The mechanism that leads
to the formation of heterochromatin markers in vivo is
unclear both in genes with repeat expansions and more
generally in normal genes. Recent literature suggests the
involvement of RNA processing in the generation of tran-
scriptional silent chromatin60,61, as well as a connection
between chromatin modiﬁcation and pre-mRNA splic-
ing.62 We can speculate that the GAA-mediated changes
observed in the minigene transcript along with the bound
splicing factors inﬂuence the epigenetic status of the FXN
gene. Common pathways might connect the altered chro-
matin conformation found in patients’ cells with changes
in pre-mRNA processing, and the exploration of these
links might provide new insight into the FRDA pathogen-
esis and lead to the development of new therapeutic
strategies.The American Journal of Human Genetics 83, 77–88, July 2008 85
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